FDA Approves Neurolief’s At-Home Neuromod for Depression

from TheBrief.Health · host TheBrief.Health

Neurolief’s FDA-approved Proliv Rx offers at-home, non-invasive neuromodulation for adults with treatment-resistant depression, expanding access to personalized care beyond traditional medications.

Episode metadata supplied by the publisher feed · Published Jun 2, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

FDA Approves Neurolief’s At-Home Neuromod for Depression

0:00 1:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

A Growing Movement Aims to Prepare All Physicians to Care for Older Adults

Apr 15, 2026 ·12m

Home Sweet Home: The Rise of Senior Home Care

Mar 20, 2026 ·13m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on June 2, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!